The Dermatologic Manifestation of Hyperandrogenism: A Retrospective Chart Review

    Image of study
    TLDR Most women with hyperandrogenism first show acne, and skin conditions like hirsutism and acanthosis nigricans are good indicators of the condition.
    In a retrospective chart review aimed at evaluating the cutaneous features and metabolic findings in women with hyperandrogenism, it was found that the most common skin manifestation at first presentation was acne, affecting 88% of patients, with 62% classified as moderate to severe. Other frequent dermatologic presentations included hirsutism (58%), acanthosis nigricans (53%), androgenic alopecia (32%), and skin tags (31%). The most common systemic sign was oligomenorrhea, occurring in 74% of the women surveyed. The study also identified acanthosis nigricans and hirsutism as useful clinical markers for hyperandrogenism, while androgenic alopecia was not. The free androgen index was determined to be a strong marker of hyperandrogenism. This study provided insights into the diverse manifestations of hyperandrogenism in women.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 7 results

      community DHT levels after 4 weeks of Fina and 8 weeks of Fina + 4 weeks of Duta

      in Update  35 upvotes 5 years ago
      The user reported early stage diffuse hair thinning and increased DHT levels after 4 weeks on Finasteride and 8 weeks on Finasteride plus 4 weeks on Dutasteride, despite the medications being authentic and stored properly. They are considering increasing their Dutasteride dosage due to the lack of side effects and are unsure if the treatment is helping their hair.

      community Proposed new pathogenesis model for androgenetic alopecia (AGA)

      in Research/Science  8 upvotes 1 year ago
      The conversation discusses a new model for understanding androgenetic alopecia (AGA), linking it to dietary and lifestyle factors similar to PCOS, and highlighting the role of DHT, vascular damage, and inflammation. Treatments mentioned include Minoxidil, finasteride, and RU58841.

      community Spironolactine Update: 2 months (34, Female)

      in Female  23 upvotes 8 years ago
      A female user's experience using Spironolactone to treat Female Pattern Hair Loss (FPHL) and Androgenic Alopecia, as well as discussing the effectiveness of the drug at different dosages.

      community Quit vaping/smoking = 80% less loss

      in Research/Science  235 upvotes 11 months ago
      Quitting vaping significantly reduced hair loss for a user who was a heavy vaper and also taking finasteride. Some participants suggest nicotine's vasoconstrictive properties may worsen hair loss, while others share personal anecdotes of hair improvement after quitting smoking or vaping.

    Related Research

    5 / 5 results